Why the study?
Do low-molecular-weight heparins prevent venous thromboembolism and improve survival in cancer patients compared to other antithrombotics?
Do low-molecular-weight heparins prevent venous thromboembolism and improve survival in cancer patients compared to other antithrombotics?
Low-molecular-weight heparins offer practical advantages for VTE prophylaxis in cancer patients and may provide additional survival benefits through potential antitumor effects.
Answers are grounded in this paper and cite their sources.
LMWH remain an option for VTE prophylaxis in cancer; antitumor survival effect is hypothesis-generating and requires prospective confirmation.
Cancer patients are at increased risk of venous thromboembolism due to a range of factors directly related to their disease and its treatment. Given the high incidence of post-surgical venous thromboembolism in cancer patients and the poor outcomes associated with its development, thromboprophylaxis is warranted. A number of evidence-based guidelines delineate anticoagulation regimens for venous thromboembolism treatment, primary and secondary prophylaxis, and long-term anticoagulation in cancer patients. However, many give equal weight to several different drugs and do not make specific recommendations regarding duration of therapy. In terms of their efficacy and safety profiles, practicality of use, and cost-effectiveness the low-molecular-weight heparins are at least comparable to, and offer several advantages over, other available antithrombotics in cancer patients. In addition, data are emerging that the antithrombotics, and particularly low-molecular-weight heparins, may exert an antitumor effect which could contribute to improved survival in cancer patients when given for long-term prophylaxis. Such findings reinforce the importance of thromboprophylaxis with low-molecular-weight heparin in cancer patients.
No takes yet. Share an insight, caveat, or question.
Francisco Robert (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: